STOCK TITAN

Astrotech Reports Fiscal Year 2026 Financial Results

Lower gross profit and stockholders’ equity accompanied a wider annual net loss, despite reduced operating expenses.

(Moderate)
(Positive)
Tags

Astrotech (ASTC) reported fiscal 2026 revenue of $913,000 for the year ended June 30, 2026.

Revenue was $1.049 million a year earlier, while gross profit fell to $217,000 from $475,000. Operating expenses were $14.355 million, down from $15.209 million, but the net loss widened to $14.427 million from $13.850 million. Cash and cash equivalents plus short-term investments totaled $11.3 million at June 30, 2026. Stockholders’ equity was $16.172 million, down from $22.100 million a year earlier.

Astrotech had deployed its TRACER 1000 at approximately 37 locations in 16 countries as of June 30, 2026, and launched the Labrador handheld gas chromatograph. Its board also approved an initiative through the newly formed Lunar Power and Light subsidiary to explore potential lunar resource and infrastructure opportunities.

Loading...
Loading translation...

Positive

  • None.

Negative

  • Revenue: $913,000 versus $1.049 million a year earlier
  • Gross profit: $217,000 versus $475,000 a year earlier
  • Stockholders’ equity: $16.172 million versus $22.100 million a year earlier

News Explained

Astrotech reported completed fiscal 2026 results; common shares outstanding were 1,998,734 at June 30, 2026, versus 1,758,953 a year earlier, reducing the percentage of common shares represented by an unchanged holding.

Argus 15 min delay 2 alerts
-2.37% vs previous close $7.01 last price 0.1x rel. volume Open Argus
Details

Market Reaction – ASTC

-7.3% Trough Tracked
$7.01 $7.38 Day Range
$14.77M Market Cap

On Sep 25, the day this news came out, the latest delayed price for ASTC is 2.37% below the previous close. Argus tracked a trough of -7.3% from its starting point during tracking. Our momentum scanner has recorded 2 alerts for this stock so far that day. The latest delayed price is $7.01.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

The effective S-3 shelf registered securities with an aggregate initial offering price of $200,000,0...
Analysis

The effective S-3 shelf registered securities with an aggregate initial offering price of $200,000,000, a relevant financing record alongside this annual-results release; supplied data does not state remaining capacity.

Key Figures

Revenue: $913 thousand (FY2026) vs. $1,049 thousand (FY2025) Gross profit: $217 thousand (FY2026) vs. $475 thousand (FY2025) Total operating expenses: $14,355 thousand (FY2026) vs. $15,209 thousand (FY2025) +4 more
Revenue
$913 thousand (FY2026) vs. $1,049 thousand (FY2025)
Fiscal years ended June 30
Gross profit
$217 thousand (FY2026) vs. $475 thousand (FY2025)
Fiscal years ended June 30
Total operating expenses
$14,355 thousand (FY2026) vs. $15,209 thousand (FY2025)
Fiscal years ended June 30
Net loss
$14,427 thousand (FY2026) vs. $13,850 thousand (FY2025)
Fiscal years ended June 30
Net loss per common share
$8.49 (FY2026) vs. $8.32 (FY2025)
Basic and diluted
Cash and short-term investments
$11.3 million
As of June 30, 2026
TRACER 1000 deployment
Approximately 37 locations in 16 countries
As of June 30, 2026

Previous Earnings Reports

1 past event · Latest: Sep 25
Same Type 1 event
  1. Sep 25

    Annual earnings

    24h Move
    +2.0%

    Fiscal 2025 revenue declined to $1.0 million, attributed to lower device sales at 1st Detect.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

mass spectrometry, gas chromatography, available-for-sale securities, convertible preferred stock
4 terms
mass spectrometry technical
"is a mass spectrometry company"
Mass spectrometry is a laboratory technique that identifies and measures chemicals by giving molecules an electrical charge and sorting them by how fast they move, like weighing and separating coins to see which kinds are present. For investors, its results are evidence used in drug development, quality control, food and environmental testing, and diagnostics, so clear mass-spec data can affect regulatory approval, product reliability, costs and market confidence.
gas chromatography technical
"integrate gas chromatography and mass spectrometry"
An analytical lab method that separates and measures the different chemical components in a gas or volatile liquid sample, like sorting runners by speed on a racetrack so each can be identified and counted. Investors care because results from gas chromatography verify product purity, safety and regulatory compliance, detect contaminants or quality problems that can trigger recalls or fines, and influence production costs and market trust.
available-for-sale securities financial
"Available-for-sale securities: Net unrealized gain"
Available-for-sale securities are investments in stocks, bonds or similar instruments that a company does not intend to trade frequently but may sell before they mature. They matter to investors because changes in the market value of these holdings show up as paper gains or losses on the company's balance sheet rather than immediately in profit, so they can affect reported net worth and the timing of income without changing day-to-day earnings. Think of them like items on a household shelf you might sell later: their value moves with the market even if you haven’t cashed out.
convertible preferred stock financial
"Convertible preferred stock, $0.001 par value"
Convertible preferred stock is a special class of company shares that pays priority, usually fixed, payments to holders and can be exchanged later for a set number of common shares. It matters to investors because it combines steady income and added protection with the chance to share in a company’s upside; think of it as a hybrid between a bond that pays regularly and an option to convert into growth-oriented stock, where the conversion rules influence both potential gains and how much common shareholders’ ownership may be reduced.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

AUSTIN, Texas, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the fiscal year ended June 30, 2026.

Financial Highlights & Fiscal Year Developments 

  • As of June 30, 2026, the Company had deployed the TRACER 1000 in approximately 37 locations in 16 countries across the United States, Europe and Asia.

  • The Company launched its Labrador ruggedized Handheld Gas Chromatograph designed to bring laboratory-grade volatile organic compound analysis directly to the point of investigation.

  • The Board of Directors of the Company approved a strategic initiative focused on potential future lunar resource development, autonomous lunar industrial infrastructure, Moon based advanced computing, semiconductor, manufacturing, lunar power generation and power infrastructure, mining, chemical manufacturing, product transportation and equipment leasing opportunities on the Moon through its newly formed subsidiary, Lunar Power and Light Corporation. As part of the initiative, Astrotech intends to evaluate and potentially develop infrastructure technologies that could support semiconductor processing, advanced computing systems, and quantum computing manufacturing operations on the lunar surface.

  • Total operating expenses were $14 million, a decline of 6% during the fiscal year ended June 30, 2026, compared to the fiscal year ended June 30, 2025.

  • Astrotech’s consolidated balance sheet consisted of $11.3 million in cash and cash equivalents and short-term investments as of June 30, 2026, which the Company believes will support operating expenses and capital expenditure requirements.

“Our fiscal year 2026 results reflect an important period of investment and progress. We have advanced several priorities that strengthen the foundation for scalable growth, including the launch of our new lunar resource and infrastructure strategic initiatives. We believe these initiatives could expand our addressable opportunities and position us to better serve customers over the long term. We enter the new year focused on executing on these opportunities with the goal of converting pipeline opportunities into revenue growth,” stated Thomas B. Pickens, III, Astrotech’s Chairman, Chief Executive Officer and Chief Technology Officer.

About Astrotech Corporation

Astrotech (Nasdaq: ASTC) is a mass spectrometry company that creates, operates, and scales innovative businesses through its wholly owned subsidiaries. Each subsidiary leverages Astrotech’s core technology to serve specialized markets:

  • 1st Detect develops, manufactures, and markets trace detection systems for security and narcotics screening applications.
  • AgLAB designs process analyzers tailored to the agriculture industry.
  • Pro-Control produces solutions for in-situ chemical process control in industrial manufacturing.
  • EN-SCAN, Inc. delivers portable, ruggedized environmental testing solutions that integrate gas chromatography and mass spectrometry for use in challenging field environments.
  • Lunar Power and Light focused on potentially developing infrastructure technologies that could support semiconductor processing, advanced computing systems, and quantum computing manufacturing operations on the lunar surface.

Astrotech is headquartered in Austin, Texas. For more information, visit www.astrotechcorp.com

Forward-Looking Statements

This press release contains “forward-looking statements” that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These statements may be identified by terms such as “aims,” “anticipates,” “believes,” “contemplates,” “continue,” “could,” “estimates,” “expect,” “forecast,” “guidance,” “intends,” “may,” “plans,” “possible,” “potential,” “predicts,” “preliminary,” “projects,” “seeks,” “should,” “targets,” “will” or “would,” or the negatives of these terms, variations of these terms or other similar expressions. These forward-looking statements include, but are not limited to, the adverse impact of inflationary pressures, including significant increases in fuel costs, global economic conditions and events related to these conditions, including the ongoing wars in Ukraine and the middle east, the Company’s use of proceeds from the common stock offerings, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, whether the market will accept our products and services and whether we are successful in identifying, completing and integrating acquisitions, the Company’s lunar infrastructure initiatives, potential NASA selection, funding, awards or contracts, technology development, partnerships, autonomous systems, lunar resource mining and processing, advanced manufacturing, power development, artificial intelligence, quantum computing, advanced semiconductor materials and commercial lunar activity, future engineering and testing, technology qualification, commercialization and potential lunar resource deployment and long-duration energy storage; and the Company's ability to finance, validate, launch, operate or commercialize related systems, and the potential effects of the addition of advisors, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. 

Any forward-looking statements in this document should be evaluated in light of these important risk factors. The contemplated lunar energy-storage application remains in the evaluation and development stage. While we do not intend to directly harvest, manufacture, distribute or sell cannabis or cannabis products, we may be detrimentally affected by a change in enforcement by federal or state governments and we may be subject to additional risks in connection with the evolving regulatory area and associated uncertainties. Any such effects may give rise to risks and uncertainties that are currently unknown or amplify others mentioned herein. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. In addition, any forward- looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to correct or update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Company Contact: 
Scott Bartley
Interim Chief Financial Officer, Astrotech Corporation
(512) 485-9530

Tables follow

ASTROTECH CORPORATION
Consolidated Statements of Operations and Other Comprehensive Loss
(In thousands, except per share data)

  June 30, 
  2026  2025 
Revenue $913  $1,049 
Cost of revenue  696   574 
Gross profit  217   475 
Operating expenses:        
Selling, general and administrative  7,871   7,067 
Research and development  6,484   8,142 
Total operating expenses  14,355   15,209 
Loss from operations  (14,138)  (14,734)
Interest and dividend income  471   1094 
Realized loss  (543)  (5)
Other income and expense, net  (213)  (203)
Total other income(expense)  (285)  886 
Loss from operations before income taxes  (14,423)  (13,848)
Income tax benefit /(expense)  (4)  (2)
Net loss $(14,427) $(13,850)
Weighted average common shares outstanding:        
Basic and diluted  1,700   1,665 
Basic and diluted net loss per common share:        
Net loss per common share $(8.49) $(8.32)
Other comprehensive loss, net of tax:        
Net loss $(14,427) $(13,850)
Available-for-sale securities:        
Net unrealized gain  548   313 
Total comprehensive loss $(13,879) $(13,537)
         


ASTROTECH CORPORATION
Consolidated Balance Sheets
(In thousands, except share and per share data)

  June 30, 
  2026  2025 
Assets        
Current assets        
Cash and cash equivalents $8,387  $3,100 
Short-term investments  2,947   15,108 
Accounts receivable  124   485 
Inventory, net:        
Raw materials  2,926   2,194 
Work-in-process  9   425 
Finished goods  1,179   310 
Prepaid expenses and other current assets  354   353 
Total current assets  15,926   21,975 
Property and equipment, net  2,383   2,395 
Intangible assets, net  50   48 
Operating lease right-of-use assets, net  1,834   2,225 
Other assets, net  314   346 
Total assets $20,507  $26,989 
Liabilities and stockholders’ equity        
Current liabilities        
Accounts payable $581  $1,066 
Payroll related accruals  482   529 
Accrued expenses and other liabilities  912   451 
Lease liabilities, current  282   405 
Total current liabilities  2,257   2,451 
Accrued expenses and other liabilities, net of current portion  54   164 
Lease liabilities, net of current portion  2,024   2,274 
Total liabilities  4,335   4,889 
Commitments and contingencies (Note 14)        
Stockholders’ equity        
Convertible preferred stock, $0.001 par value, 2,500,000 shares authorized; 280,898 shares of Series D issued and outstanding at June 30, 2026 and 2025, respectively  —   — 
Common stock, $0.001 par value, 250,000,000 shares authorized at June 30, 2026 and 2025 respectively; 2,009,050 and 1,769,269 shares issued at June 30, 2026 and 2025 respectively; 1,998,734 and 1,758,953 outstanding at June 30, 2026 and 2025, respectively  190,643   190,643 
Treasury shares, 10,316 shares at June 30, 2026 and 2025, respectively  (119)  (119)
Additional paid-in capital  91,261   83,310 
Accumulated deficit  (265,297)  (250,870)
Accumulated other comprehensive loss  (316)  (864)
Total stockholders’ equity  16,172   22,100 
Total liabilities and stockholders’ equity $20,507  $26,989 



FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How did Astrotech’s operating expenses change in fiscal 2026?

Operating expenses fell to $14.355 million from $15.209 million in fiscal 2025. Research and development expenses declined to $6.484 million from $8.142 million, while selling, general and administrative expenses rose to $7.871 million from $7.067 million.

Keep reading